Eduard’s project “Ribonucleotide reductase: a novel therapeutic target against bacterial pathogens in cystic fibrosis patients” is funded by the Federación Española de Fibrosis Quística and the Associació Catalana de Fibrosi Quística.
Read the issue here.
